Parkinson's Disease Online Powered by the Michael J. Fox Foundation Home
Welcome Guest | Be a part of PD Online Research
  • recover password
FacebookTwitter
  • Discussions
    • LRRK2 Antibodies
    • Protocol Q&A
  • News
    • Papers of the Week
    • Newsletters
  • Resources
    • Genes
    • Research Models
    • Clinical Trials
    • Classifieds
    • PD Guide
  • Funding
    • Funding News
  • Meetings
    • Calendar
    • Meeting Reports
    • Reporter Awards
  • Members
    • Member Directory
    • Apply for Membership

Biblio

  • List
  • Filter
Add Citation
Export 6 results:
  • Endnote
Sort by: Author Title Type [ Year (Desc)]
Filters: Author is Gitler, Aaron D  [Clear All Filters]
2010
Xiong Y, Coombes CE, Kilaru A, Li X, Gitler AD, Bowers WJ, et al. GTPase activity plays a key role in the pathobiology of LRRK2. PLoS Genet. 2010;6(4):e1000902.
  • Endnote
  • 0
Moore DJ, Dawson VL, Dawson TM, Gitler AD, Xiong Y, Bowers WJ, et al. GTPase Activity Plays a Key Role in the Pathobiology of LRRK2. PLoS Genetics. 2010;6.
  • Endnote
  • 0
2009
Gitler AD, Chesi A, Geddie ML, Strathearn KE, Hamamichi S, Hill KJ, et al. Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat Genet. 2009;41(3):308-15.
  • Endnote
  • 0
Rappley I, Gitler AD, Selvy PE, LaVoie MJ, Levy BD, Brown AH, et al. Evidence that alpha-synuclein does not inhibit phospholipase D. Biochemistry. 2009;48(5):1077-83.
  • Endnote
  • 0
2008
Gitler AD, Bevis BJ, Shorter J, Strathearn KE, Hamamichi S, Su L, et al. The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis. Proc Natl Acad Sci USA. 2008;105(1):145-50.
  • Endnote
  • 0
2006
Cooper AA, Gitler AD, Cashikar A, Haynes CM, Hill KJ, Bhullar B, et al. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science. 2006;313(5785):324-8.
  • Endnote
  • 0

Latest Discussions

  • 2010 PD Therapeutics Conference
    Responses: 1
  • Utility of pharmacometric approaches for PD clinical trial design
  • Q&A with Roger Barker of Cambridge University
  • Papers of the Week: July 26, 2010
  • New Diagnostic Guidelines for Alzheimer's Disease
    Responses: 1
more

Latest News

  • Update: LRRK2 Antibody Feedback Posted
    30 Jul 2010
    We've sent out LRRK2 antibodies to over 160 labs, and more than half have submitted their data to MJFF so far. Our summary, posted on the LRRK2 antibody discussion page, points out the strengths and ... 
  • Funding Available for Novel Biomarkers for Frontotemporal Dementias
    28 Jul 2010
    The Alzheimer’s Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Dementias (AFTD) have announced funding opportunities for research on frontotemporal dementias. The ... 
  • Amarantus Receives Notice of Allowance from EPO
    28 Jul 2010
    The European Patent Office (EPO) has given Amarantus Therapeutics a Notice of Allowance on mesencephalic astrocyte-derived neurotrophic factor (MANF), which is in preclinical development. According ... 
  • NINDS Wants Your Input
    28 Jul 2010
    The National Institute of Neurological Disorders and Stroke (NINDS) wants to know what researchers think about tool and resource development needs in the neuroscience and neurology fields.  ... 
more

Upcoming Events

  • Webinar: Clinical Trial Design for Anti-Dyskinetic Therapies
    03 Aug 2010
  • IACUC 101 and 201 PLUS Workshops (NIH)
    18 Aug 2010 - 19 Aug 2010
  • Symposium on Systems Approaches to Parkinsons Disease
    18 Aug 2010 - 19 Aug 2010
more

Funding Opportunities

  • PD Objective Measures
    The Kinetics Foundation
    01 Aug 2010
  • Requests for Research Proposals and for Retrospective Data-Mining Projects in Parkinson's Disease and Related Disorders
    Parkinson Study Group, Parkinson's Disease Foundation
    02 Aug 2010
  • Competing Renewal Awards of SBIR Phase II Grants for Brain and Behavior Tools (R44)
    NINDS
    05 Aug 2010
  • High Throughput Tools for Brain and Behavior (SBIR [R43/R44])
    NINDS
    05 Aug 2010
  • High Throughput Tools for Brain and Behavior (STTR [R41/R42])
    NINDS
    05 Aug 2010
more
  • About
  • Terms
  • who we are
  • The Michael J. Fox Foundation
  • Posting Tips
  • how to cite us
  • contact us
FacebookTwitter